Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/18608 |
Resumo: | Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? This empirical research evaluates whether the Pfizer-Wyeth merger created value for shareholders, trying to assess if the specific case study is in line with the principal pattern of the industry. In order to achieve these goals, a detailed value creation appraisal is implemented through market reaction measurement at the announcement dates of acquisition. Afterward, a statistical regression has been performed determining which factors mainly affect enterprise’s performance. The conclusion suggests that the deal’s value creation is aligned with the pharmaceutical industry trend and that company performance is affected by financing structure, EPS and transaction size. |
id |
RCAP_9a355359e9d7ee47a42ef040a68061fe |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/18608 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry?Merger and AcquisitionValue creationPfizerPharmaceutical sectorDomínio/Área Científica::Ciências Sociais::Economia e GestãoIs Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? This empirical research evaluates whether the Pfizer-Wyeth merger created value for shareholders, trying to assess if the specific case study is in line with the principal pattern of the industry. In order to achieve these goals, a detailed value creation appraisal is implemented through market reaction measurement at the announcement dates of acquisition. Afterward, a statistical regression has been performed determining which factors mainly affect enterprise’s performance. The conclusion suggests that the deal’s value creation is aligned with the pharmaceutical industry trend and that company performance is affected by financing structure, EPS and transaction size.Ferraz, Duarte PittaRUNAngelis, Ilaria De2017-06-20T00:30:16Z2016-062016-062016-06-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/18608TID:201988178enginfo:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T03:57:57Zoai:run.unl.pt:10362/18608Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:24:52.433950Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? |
title |
Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? |
spellingShingle |
Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? Angelis, Ilaria De Merger and Acquisition Value creation Pfizer Pharmaceutical sector Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
title_short |
Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? |
title_full |
Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? |
title_fullStr |
Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? |
title_full_unstemmed |
Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? |
title_sort |
Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? |
author |
Angelis, Ilaria De |
author_facet |
Angelis, Ilaria De |
author_role |
author |
dc.contributor.none.fl_str_mv |
Ferraz, Duarte Pitta RUN |
dc.contributor.author.fl_str_mv |
Angelis, Ilaria De |
dc.subject.por.fl_str_mv |
Merger and Acquisition Value creation Pfizer Pharmaceutical sector Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
topic |
Merger and Acquisition Value creation Pfizer Pharmaceutical sector Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
description |
Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? This empirical research evaluates whether the Pfizer-Wyeth merger created value for shareholders, trying to assess if the specific case study is in line with the principal pattern of the industry. In order to achieve these goals, a detailed value creation appraisal is implemented through market reaction measurement at the announcement dates of acquisition. Afterward, a statistical regression has been performed determining which factors mainly affect enterprise’s performance. The conclusion suggests that the deal’s value creation is aligned with the pharmaceutical industry trend and that company performance is affected by financing structure, EPS and transaction size. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-06 2016-06 2016-06-01T00:00:00Z 2017-06-20T00:30:16Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/18608 TID:201988178 |
url |
http://hdl.handle.net/10362/18608 |
identifier_str_mv |
TID:201988178 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/embargoedAccess |
eu_rights_str_mv |
embargoedAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137881749454848 |